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Abstract
The aim of this essay is the self assessment of the level of knowledge of the 2004 WHO classification of bladder
neoplasms through a series of MCQs, each associated a short commentary. This paper is directed to all who are
involved with the application of this classification at the anticancer research, diagnostic, prognostic and therapeutic
levels, in particular to uropathologists, urologists and oncologists.
Introduction
The 1973 WHO histological grading of bladder cancer is
one of most successful grading systems among all organ
sites and has been validated since its introduction three
decades ago. In 1998, a system of classifying non-inva-
sive flat and papillary urothelial neoplasms of the urin-
ary bladder was proposed by the International Society of
Urologic Pathology in association with the World Health
Organization. This became known as the 1998 WHO/
ISUP classification system [1]. In 2004, this classification
system was adopted in Pathology and Genetics of
Tumours of the Urinary System and Male Genital
Organs, one of a series of WHO “Blue Books” for the
classification of tumours (Additional file 1: Appendix 1).
This is known as the 2004 WHO classification [2].
This paper is directed to all who are involved with the
application of this classification at the anticancer
research, diagnostic, prognostic and therapeutic levels,
in particular to uropathologists, urologists and oncolo-
gists. The aim of this essay is to test the level of knowl-
edge of the 2004 classification through a series of
MCQs, each associated a short commentary. Additional
file 2: Appendix 2 can be used by the readers to record
the correct answers. The list with the correct answers
will be published in the next journal issue. Those inter-
ested to discuss the MCQs with the authors of this con-
tribution should contact the corresponding author.
Multiple choice questions and explanatory notes
Question No 1. Normal urothelium. Which of the followings
items is wrong?
1. It is the type of epithelium lining the urinary blad-
der, ureters, and renal pelvis
2. Its thickness varies with the state of distension of
the bladder
3. By immunohistochemistry it shows reactivity for
CK20 only in the basal cell layer
4. Frequently technical problems such as tangential
cut, thick sections and vagaries of staining and fixa-
tion may cause the normal urothelium appear hyper-
chromatic and hyperplastic
Explanatory notes
Urothelium (Figure 1) is a multilayered epithelium of
the urinary bladder, ureters, and renal pelvis in which
the cells mature to form the very large surface “umbrella
cells.” The thickness of the normal urothelium varies
with the state of distension of the bladder (2 to 4 cell
layers when dilated and 5 to 7 layers when contracted)
[3]. The urothelium of the renal pelvis, urethra and the
bladder neck is usually composed of slightly larger cells,
which have diminished cytoplasmic clearing and hence
may be misinterpreted as dysplasia. Umbrella cells may
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show some degree of nuclear pleomorphism, which
should not be misconstrued to be dysplastic. If the sec-
tions are thick, the urothelium may appear hyperchro-
matic and this artifact compounded with tangential
sectioning may result in changes felt to represent dys-
plasia. Vagaries of staining and fixation may also impart
hyperchromasia to benign nuclei. Normal urothelium
shows reactivity for CK20 only in the superficial
umbrella cell layer, while CD44 staining is limited to the
basal and parabasal urothelial cells. Nuclear staining for
p53 is absent in normal urothelium [4].
Question No 2. Flat urothelial hyperplasia. Which of the
following items is correct?
1. The diagnosis does not usually requires counting
the number of cell layers in the urothelium
2. It consists of a markedly thinned urothelium,
lower than seven cells layers thick, with minimal
cytological atypia
3. When seen by itself, there are data proving that it
has premalignant potential
4. It is a reactive process unrelated to bladder cancer
Explanatory notes
Historically the term “hyperplasia” has been equated
with counting cell layers and specifically considering the
epithelium to be hyperplastic if there were more than 7
cell layers (Figure 2). It is well recognized that the
apparent number of cell layers in the normal urothelium
is variable and dependent on the state of contraction of
the bladder wall. The 2004 classification recognizes
hyperplasia as when there is a “markedly thickened
mucosa without atypia.” Counting cell layers is not
recommended. The relationship between hyperplasia
and neoplasia is unknown [2,5,6].
Question No 3. Reactive atypia. Which of the followings is
correct?
1. It is a preneoplastic lesion
2. It is a synonymous of flat dysplasia
3. It consists of cytological abnormalities occurring
in acutely or chronically inflamed urothelium
4. It never coexists with dysplasia or in situ
carcinoma
Explanatory notes
In the presence of acute and/or chronic inflammation,
the urothelium shows a wide range of reactive changes
(Figure 3). There is usually a history of instrumentation,
infection or treatment with intravesical agents. Some
patterns of atypia are associated with specific aetiologies.
In reactive atypia the epithelium may or may not be
thickened. Although a thickened epithelium is typically
associated with a reactive process, carcinoma in situ can
also produce a thicker than normal epithelium. Nuclei
are uniformly enlarged, vesicular, and may have promi-
nent usually centrally located nucleoli. Mitoses may be
frequent and are in the lower epithelial layers. Inflam-
mation is almost always present [2].
Figure 1 Normal urothelium.
Figure 2 Flat urothelial hyperplasia.
Figure 3 Reactive atypia.
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Question No 4. Papillary urothelial hyperplasia
(Pseudopapillary hyperplasia). Which of the followings is
correct?
1. Well-developed branching fibrovascular cores are
present
2. Urothelium exhibiting a slight “tenting”, undulat-
ing, or papillary growth; often there are one or sev-
eral dilated capillaries at the base of the lesion
3. It is not a preneoplastic lesion/condition
4. This term is also used to describe polypoid cystitis
Explanatory notes
In the 1998 WHO/ISUP classification, papillary hyperpla-
sia was included as a category with the group of papillary
lesions [1]. In the 2004 WHO classification, this is no
longer included as a specific designation but it is recog-
nized that hyperplasias may be flat or pseudopapillary (Fig-
ure 4) [2]. In the current classification, hyperplasia with a
pseudopapillary architecture refers to a slight tenting or
undulation of the urothelium lacking a well defined central
fibrovascular core, although small vessels may be present
at the base of the papillae. There is no significant cytologic
or architectural atypia. These have most often been
described in the setting of known papillary neoplasia.
When identified de novo the significance regarding subse-
quent development of neoplasia is unknown.
Question No 5. Urothelial dysplasia Which of the
followings is correct?
1. There is no evidence that dysplasia may be a pre-
cursor of invasive carcinoma
2. The natural history of dysplasia in humans is
poorly understood. There is some evidence that dys-
plasia may be a precursor of invasive carcinoma
3. It consists of a markedly thickened urothelium,
greater than seven cells layers thick, with cytological
atypia
4. The thickness of the urothelium and the polarity
of the cells are maintained
Explanatory notes
Histologically there is some architectural distortion. The
nuclei are irregularly enlarged with some hyperchromasia
and pleomorphism present. Overall the features are those
of a neoplastic atypia but fall short of the criteria for car-
cinoma in situ outlined below (Figure 5). This category
also suffers from a significant problem in diagnostic
reproducibility. The natural history of lesions with dys-
plastic features of a lesser degree than the moderate to
severe categories is unknown. There is however some
evidence, largely genetic that it shares some abnormal-
ities with CIS and therefore likely represents a precursor
lesion. It is most often diagnosed in the context of
known urothelial neoplasia. One study that applied the
1998 WHO/ISUP criteria indicated a 15% risk of devel-
oping cancer with a mean follow up of 4.9 years [7].
Question No 6. Carcinoma in situ of the urothelium. Which
of the followings is wrong?
1. The type of atypia often seen in invasive urothelial
carcinoma
Figure 4 Papillary urothelial hyperplasia (pseudopapillary
hyperplasia). Figure 5 Urothelial dysplasia.
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2. It is histologically characterized by unequivocal
severe cytological atypia
3. A common feature of CIS is the lack of intercellu-
lar cohesion resulting in extensive denudation
4. Human polyoma virus infection might result in
the development of CIS
Explanatory notes
Histologically CIS is characterized by architectural dis-
order and nuclear pleomorphism (Figure 6). The cyto-
logically atypical cells need not involve the full
thickness of the epithelium and at the minimum single
malignant cells growing in a pagetoid fashion are suffi-
cient for the diagnosis of CIS. Individual cells tend to
show marked cytological atypia but increased N:C ratio
is not a prerequisite (not present in the large cell type
of CIS). In some cases only a few isolated cells are pre-
sent clinging to the basement membrane (denuding
CIS).
The classification recognizes the need to expand the
category of CIS to include lesions that had been graded
in the severe dysplasia category in previous systems.
This change reflects current practice in major institu-
tions treating bladder cancer. There is recognition that
this is the most reproducible diagnostic category. CIS is
accepted as a direct precursor of invasive carcinoma.
The development of invasion is seen in the follow-up in
20 to 30% of the cases [2,5,8].
Question No 7. Papillary urothelial neoplasm of low
malignant potential. Which of the followings is correct?
1. Papillae with minimal architectural abnormalities
and nuclear atypia, with more cell layers than
papilloma
2. Papillary urothelial neoplasm of low malignant
potential is associated with invasion or metastasis
3. Follow-up of the patient is not needed
4. Patients are not at an increased risk of developing
recurrent or new papillary lesions usually of similar
histology
Explanatory notes
Morphologically PUNLMP largely, though not comple-
tely, corresponds to grade 1 papillary carcinoma in the
old WHO system (Figure 7). The tumour consists of
delicate papillae with little or no fusion. The covering
urothelium shows minimal if any architectural irregular-
ity. Nuclei are roughly normal in size, lack significant
nuclear hyperchromasia or pleomorphism. The chroma-
tin is fine and nucleoli are inconspicuous. Mitoses are
infrequent and basally located. These tumors have a sig-
nificantly lower rate of recurrence than either low- or
high-grade papillary carcinomas and a very low rate of
stage progression [5,9]. In a review of published studies,
Lopez-Beltran [5,8] found the mean tumour recurrence
rate to be 36% and stage progression rate to be 3.7%.
Question No 8. Low-grade papillary urothelial carcinoma.
Which of the followings is correct?
1. This lesion is usually associated with invasion or
metastases at the time of presentation
1. Mitotic figures, including atypical forms, are fre-
quently seen at all levels
2. Low grade papillary urothelial carcinomas have a
high risk of progression, with figures varying from
15% to 40%, and of association with invasive disease
at the time of diagnosis
3. The urothelium lining the papillae is similar to
flat urothelial dysplasia
Explanatory notes
This category contains the intermediate group of lesions.
In the 1973 WHO system this would include the lower
Figure 6 Carcinoma in situ of the urothelium.
Figure 7 Papillary urothelial neoplasm of low malignant
potential.
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1/2 of grade 2 papillary carcinoma. Histologically the
papillae are largely delicate and separate but some
fusion may be seen. At low magnification there is a gen-
erally ordered appearance to the cells within the epithe-
lium (Figure 8). The nuclei tend to be uniformly
enlarged and retain the elongated to oval shape of nor-
mal urothelial cells. The chromatin remains fine with
small and generally inconspicuous nucleoli. Mitoses may
be present but are few and remain basally located. The
urothelium lining the papillae is similar to flat dysplasia.
These tumors have a significantly higher recurrence rate
than for PUNLMP and similar to high-grade papillary
carcinomas. They also have a significantly higher rate of
stage progression than PUNLMP but significantly lower
than for high-grade papillary carcinoma [2,5,9]. A review
of the literature revealed a mean recurrence rate of 50%
and mean stage progression rate of 10% [5,8].
Question No 9. High-grade papillary urothelial carcinoma
Which of the followings is correct?
1. Mitotic figures are infrequent and usually seen in
the lower half of the urothelium
2. Tumour recurrence, stage progression and
tumour-related mortality occur in approximately
35%, 4% and 2% of patients, respectively
3. Tumour recurrence, stage progression and
tumour-related mortality are approximately 50%,
10% and 5%, respectively
4. High grade papillary urothelial carcinomas have a
high risk of progression, with figures varying from
15% to 40%, and of association with invasive disease
at the time of diagnosis
Explanatory notes
Tumors that in many cases would have been included in
the 1973 WHO grade 2 category (upper 1/2) have a sig-
nificant frequency of invasion and biologically have
more in common with the grade 3 tumors.
Histologically, the papillae are frequently fused forming
apparent solid masses. The overall impression is one of
disordered growth. The epithelium is of variable thick-
ness and is similar to flat CIS (Figure 9). Individual cells
are haphazardly arranged within the epithelium and
have a generally discohesive nature. Nuclei are hyper-
chromatic and pleomorphic. The chromatin is dense,
irregularly distributed and often clumped. Nucleoli may
be single or multiple and are often prominent. Mitoses
are generally frequent and may be seen at any level of
the epithelium. These tumours not only have a risk of
invasion but have a significant risk of recurrence and
progression. For this reason the consensus was that
these were better included in a high-grade category with
the traditional WHO grade 3 neoplasms. The overall
progression rate (to invasive carcinoma) ranges from
15% to 40%. These tumours, when noninvasive (pTa)
likely all require additional intravesical therapy. Hetero-
geneity of grade is recognized in papillary lesions
[2,8,10] and the consensus was that tumours should be
graded on their worst part although this needs further
study.
Question No 10. Inverted urothelial papilloma. Which of
the following statements is wrong?
1. Endophytic lesion which shares several features
with exophytic urothelial papilloma
2. Rarely, hybrid cases exist with portions of the
lesion resembling exophytic papilloma and others
inverted urothelial papilloma
3. Urothelial carcinoma may arise within inverted
urothelial papilloma
4. Urothelial nests, clusters, or single cells invading
the lamina propria
Explanatory notes
Inverted papilloma is a distinct clinical pathologic entity
typically arising in the trigone region in a younger
 
Figure 8 Low-grade papillary urothelial carcinoma. Figure 9 High-grade papillary urothelial carcinoma.
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patient population than papillary neoplasms. Grossly
inverted papilloma typically shows an exophytic poly-
poid growth pattern. Histologically it consists of anasto-
mosing trabeculae of urothelium covered by a normal or
attenuated urothelium (Figure 10). There is no signifi-
cant nuclear pleomorphism and few mitoses can be
seen. Squamous or glandular differentiation may be pre-
sent. In TUR material the fragmentation of the lesion
may result in apparent true papillary structures making
diagnosis difficult. Distinction from papillary carcinoma
with an inverted growth pattern can be problematic (See
below). Cases of synchronous inverted papilloma and
papillary carcinoma are well described. It is associated
with a low risk of recurrence (< 5%) [11]. Recent genetic
data supports the idea that inverted papilloma is not
related to papillary urothelial neoplasms [12].
Question No 11. Urothelial carcinoma with endophytic
growth patterns is
1. A variant of invasive urothelial carcinoma
2. A non-invasive urothelial carcinoma exhibiting a
prominent endophytic growth pattern resulting in
considerable difficulty in assessing invasion
3. Any invasive urothelial carcinoma
4. Does not occur in the bladder
Explanatory notes
Some papillary urothelial carcinomas exhibit a promi-
nent endophytic growth pattern resulting in consider-
able difficulty in assessing invasion [13]. Endophytic
growth is evident either as inter-anastomosing cords
and columns of urothelium, often with a striking resem-
blance to inverted papilloma (inverted papilloma-like
pattern), or as broad, pushing bulbous invaginations
into the lamina propria (broad-front pattern) (Figure
11). Distinction from inverted papilloma requires
attention to architectural and cytological features. A
diagnosis of invasion requires the unquestionable pre-
sence within the lamina propria of irregularly shaped
nests or single cells that may have evoked a desmoplas-
tic or inflammatory response. A stromal response may
be absent. In such instances, irregularity of the contours
of the invasive nests, architectural complexity, and
recognition of single-cell invasion are helpful. Occasion-
ally, the cells in the invading nests appear morphologi-
cally different from the cells at the base of the tumour,
and they may appear as smaller aggregates present
within empty spaces. These spaces may mimic vascular
invasion closely, but they are believed to be retraction
artifacts.
Question No 12. Urothelial carcinoma with lamina propria
invasion. Which of the following statements is wrong?
1. Urothelial nests, clusters, or single cells invading
the lamina propria.
2. Often associated with a desmoplastic or inflamma-
tory stromal response
3. Nests of invasive tumour within the lamina pro-
pria may exhibit prominent retraction artifact which
is frequently overdiagnosed as vascular invasion.
4. Urothelial nests invading adipose tissue is always
pT3 stage
Explanatory notes
The invasive front of the tumour may be seen as single
cells or nests or finger-like extensions (Figure 12) [9].
The infiltrating component often shows higher degree
of nuclear pleomorphism and has abundant eosinophilic
cytoplasm. Stroma may show a desmoplastic or heavy
inflammatory response. Retraction artifacts, mimicking
vascular-lymphatic invasion, are particularly frequent in
tumours superficially invading into the lamina propria
Figure 10 Inverted urothelial papilloma.
Figure 11 Urothelial carcinoma with endophytic growth
pattern.
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and should not be overdiagnosed as vascular invasion.
Vascular invasion in cases with lamina propria invasion
is uncommon and should be diagnosed only in unequi-
vocal cases or after immunohistochemistry [14]. In the
absence of stromal response the diagnosis of invasion
rely on the characteristics of the infiltrating epithelium.
Recently-emphasized pitfalls in the diagnosis of lamina
propria invasive urothelial carcinoma include tangential
sectioning, thermal artifact, obscuring inflammation, CIS
involving von Brunn nests, deceptively bland tumours
such as microcystic and nested urothelial carcinoma var-
iants, invasion into indeterminate type of muscle, and
invasion into adipose tissue within lamina propria
[14,15]. Determination of the type of muscle (muscularis
mucosae vs. muscularis propria) invaded by carcinoma
can be particularly difficult due to different problems
including: small sample size, tissue distortion, cautery
artifact, poor orientation, fibrosis and inflammation eli-
cited by destructive growth of invasive tumour, even
hypertrophy of the normally thin and discontinuous
muscularis mucosae. In those cases the designation of
“muscle type indeterminate” is a viable description [16].
Only in the last few years has the presence of adipose
tissue in all layers of the bladder including lamina pro-
pria and muscularis propria been well-documented [17].
Thus the presence of carcinoma in fat does not necessa-
rily indicate extra-vesical extension. Invasive tumour
should be graded as low-or high-grade analogous to the
scheme used for grading non-invasive lesions.
Question No 13. Urothelial carcinoma with muscularis
propria invasion. Which of the statements is wrong
1. Tumour cells infiltrate thick muscle bundles
2. Urothelial nests, clusters, or single cells within the
subepithelial connective tissue
3. Is much more aggressive than low-grade
carcinoma
4. In a TUR specimen there should be no attempt to
substage the depth of muscularis propria invasion
Explanatory notes
(See also comments related to MCQ 12) The level of
invasion of the lamina propria is related to patient out-
come, with a worse prognosis for tumours that invade
beyond the muscularis mucosae (pT1b) [14] or deeply
into the subepithelial connective tissue, as quantitated
using an ocular micrometer. The WHO 2004 group
recommended that some estimate of extent of lamina
propria invasion (for example: pT1a - above or into
muscularis mucosae vs. pT1b - tumours below) (Figure
13) [2] be provided but this is currently not a formal
part of the 2002 TNM system, and it is not universally
reported, since there is no established method that is
consistently applicable and reproducible. In fact it is
often difficult to identify the depth of lamina propria
invasion due to the lack of orientation in the transure-
thral resection (TUR) chips or because of the absence of
muscularis mucosae and thick-walled vessels. Neverthe-
less, pathologists are encouraged to provide some
assessment as to the extent of lamina propria invasion.
If the tumour invades muscularis mucosae, it should be
mentioned in the report unambiguously so that the
urologist does not confuse muscularis mucosae with
muscularis propria. The presence or absence of
Figure 12 Urothelial carcinoma with lamina propria invasion.
Figure 13 Urothelial carcinoma with muscolaris propria
invasion.
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muscularis propria in the specimen should always be
mentioned, even in cases of noninvasive disease, with
the purpose of giving feedback to the urologist as to the
depth of the biopsy [14].
Question No 14. Urothelial carcinoma with muscularis
propria invasion. Which of the statements are correct
1. Substaging of pT2 (pT2a, invasion of “superficial”
muscle or inner half, vs. pT2b, invasion of deep
muscle or outer half) can only been done on radical
cystectomy specimens
2. Muscularis mucosae invasion is synonymous to
muscularis propria invasion
3. The presence or absence of muscularis propria in
biopsy and transurethral resection of bladder tumour
samples, and presence or absence of carcinoma in
identified muscularis propria, should not be specified
4. Clinicians should accept a diagnosis of “Urothelial
carcinoma invading muscle” without demanding
further clarification from the pathologist
Explanatory notes
Invasion by bladder carcinoma into muscularis propria
(muscle wall, detrusor) is an ominous finding where the
patient becomes a candidate for radical cystectomy or
radiation therapy with or without adjuvant chemother-
apy. Special studies, such as a Masson stain or immuno-
histochemistry with antibodies to actin, help identify all
smooth muscle tissue. The highlighting of numerous
muscle fibres distributed throughout an extensive
tumour may lead to a diagnosis of muscularis propria
invasion [14]. Situations where there is uncertainty as to
the presence muscularis propria invasion should be con-
veyed to the urologist. Clinicians should not accept a
diagnosis of “TCC invading muscle” without demanding
further clarification (if possible) from the pathologist.
The presence or absence of muscularis propria in
biopsy and transurethral resection of bladder tumour
(TURBT) samples, and presence or absence of carci-
noma in identified muscularis propria, should be
specified.
Substaging of pT2 (pT2a - invasion of “superficial”
muscle = inner half vs. pT2b - invasion of “deep” mus-
cle = outer half) and distinction of pT2 vs. pT3 can
only been done on radical cystectomy specimens, and
not TURBT samples (Figure 1I, insert) [14]. Even in
cystectomy specimens it can be a challenge at times to
determine extra-vesical (pT3) spread since the bound-
ary between muscularis propria and its fat is not well-
demarcated from peri-vesical fat. Moreover, this
boundary can be distorted, obscured, or obliterated by
fibrosis and inflammation associated with infiltrating
tumour.
Question No 15. Which of the following statements is
wrong
1. The WHO 2004 classification is the most current
version in bladder tumour classification.
2. The WHO 1973 classification is still considered by
many urologists and oncologists as the international
standard in patient’s management.
3. The TNM system should be preferred to the
WHO 2004 classification
4. Lesions called WHO 1973 grade 3 are by defini-
tion high-grade carcinoma in the WHO 2004 system
Explanatory notes
A major misconception is that there is a one to one
translation between the 1973 and 2004 WHO classifica-
tion systems. Only at the extremes of grades in the 1973
WHO classification, does this correlation hold true.
Lesions called papilloma in the WHO classification sys-
tem would also be called papilloma in the 2004 WHO
system. At the other end of the grading extreme, lesions
called WHO grade 3 are by definition high-grade carci-
noma in the 2004 WHO system. However, for WHO
grades 1 and 2, there is no direct translation to the
WHO/ISUP system [5].
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